Using High‐Field Magnetic Resonance Spectroscopy to Measure Muscle Glycogen in Patients With McArdle Disease
Muscle & Nerve · 2026-12 · 74 (6) · 1652-1656
DOI: 10.1002/mus.70433 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, online erschienen am 07.10.2026. Verfasst von Mads Godtfeldt Stemmerik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type V, Muscle, Skeletal, Glycogen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sanofi.
Abstract (Originalsprache)
Introduction/Aims Patients with McArdle disease demonstrate exercise intolerance with muscle contractures and episodic rhabdomyolysis. Additionally, some patients show progressive fat replacement of paraspinal and shoulder muscles with aging. The cause of fat replacement in older McArdle patients is unknown but could relate to a higher glycogen accumulation in these muscles in line with what is found in Pompe disease. The aim of the study was to investigate if this is also the case in McArdle disease, which could imply that excess levels of glycogen accumulation are a potential driver of fat replacement of muscle.
Methods
Using 7 Tesla 13 C magnetic resonance spectroscopy, we measured glycogen noninvasively in lumbar, thigh, and calf muscles in 14 patients with McArdle disease and 19 healthy controls.
Results
Patients with McArdle disease showed increased levels of glycogen in all muscles compared to controls; calf (3.2 times normal, p < 0.005), hamstrings (2.7 times normal, p < 0.005), anterior thigh compartment (2.7 times normal, p < 0.005), and lumbar muscle (2.1 times normal, p < 0.005). Glycogen was evenly distributed among muscle groups in both patients with McArdle disease and healthy controls.
Discussion
Our results are in line with previous studies showing two to three times increased glycogen compared to control in muscle biopsies. We found no variability in glycogen concentration among muscles that could indicate glycogen as a predictor of muscle injury in McArdle disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Copenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
- Danish Research Centre for Magnetic Resonance, Department of Radiology and Nuclear Medicine, Copenhagen University Hospital-Amager and Hvidovre, Copenhagen, Denmark.
ORCID-Profile: Mads Godtfeldt Stemmerik, Anna Slipsager, Vanessa Wiggermann, John Vissing
Förderung
- Sanofi
Zitieren
APA
Stemmerik, M. G., Beha, G. H., Slipsager, A., Wiggermann, V., & Vissing, J. (2026). Using High‐Field Magnetic Resonance Spectroscopy to Measure Muscle Glycogen in Patients With McArdle Disease. Muscle & Nerve, 74(6), 1652-1656. https://doi.org/10.1002/mus.70433
Vancouver
Stemmerik MG, Beha GH, Slipsager A, Wiggermann V, Vissing J. Using High‐Field Magnetic Resonance Spectroscopy to Measure Muscle Glycogen in Patients With McArdle Disease. Muscle & Nerve. 2026;74(6):1652-1656. doi:10.1002/mus.70433
BibTeX
@article{Stemmerik2026,
author = {Stemmerik, Mads Godtfeldt and Beha, Gry Hatting and Slipsager, Anna and Wiggermann, Vanessa and Vissing, John},
title = {Using High‐Field Magnetic Resonance Spectroscopy to Measure Muscle Glycogen in Patients With McArdle Disease},
journal = {Muscle & Nerve},
year = {2026},
volume = {74},
number = {6},
pages = {1652--1656},
doi = {10.1002/mus.70433}
}
EUVIMED